Asta SIAB gets Lloyd’s approval for ‘breakthrough’ biotech cover

Asta, through its third-party managing agency at Lloyd’s, has received in-principle approval of an innovative syndicate-in-a-box (SIAB) to provide a “breakthrough” insurance product that will insure exposures previously deemed ‘unsuitable’ for insurance, and help accelerate the development of new therapeutic drugs.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Insurance

Sustainability-linked insurance could become catalyst for innovation: FERMA

4 October 2026 There is potential for sustainability-linked insurance to reshape underwriting, data and resilience financing.

Insurance

Industry should strive for more than merely surviving the next storm: Swiss Re CS

2 October 2026 Amidst the challenging risk landscape, Swiss Re’s Ole Ohlmeyer argues that the insurance industry should strive for more than merely surviving the next storm.

Insurance

Supply chain visibility is critical, says Charles Taylor’s Hope

2 October 2026 Understanding supply-chain interdependencies and vulnerabilities is critical when incidents occur.